Electrophysiology

The cardiac subspecialty of electrophysiology (EP) diagnoses and treats arrhythmias. This includes use of pacemakers to treat bradycardia, implantable cardioverter defibrillators (ICD) for tachycardia, heart failure and patients at risk of sudden cardiac arrest, and cardiac ablation treatments to treat heart rhythm disorders.

Abbott PFA system gains FDA approval
The Volt Pulsed Field Ablation System from Abbott has been approved by the FDA. The technology, which gained CE mark approval in March, features a one-of-a-kind catheter design and allows patients to be treated under conscious sedation.
New PFA registry will use AI, EHR integration to gather real-world data
PFA has emerged as the preferred ablation strategy for many electrophysiologists, but some questions do remain about its long-term impact. HRS is developing this new registry to be as user-friendly for clinicians as possible.
Success in treating congenital heart disease prompted need for new adult guidelines
The American College of Cardiology and American Heart Association have issued new guidelines for the management of congenital heart disease in adults. The document outlines how to manage these patients, the challenges they face and much more.
FDA approves new nasal spray for patients with abnormal heart rhythms
Milestone Pharmaceuticals will be selling etripamil under the brand name Cardamyst. It is expected to hit the U.S. market in early 2026.
FDA clears next-generation cardiac mapping software
San Diego-based Vektor Medical first secured FDA clearance for the AI-powered technology back in 2021. This updated announcement covers the latest version, which includes atrial flutter mapping and several other new features.

From left to right: Sunita Ferns, MD; Mark Plunkett, MD; Harma Turbendian, MD. Images courtesy of OSF Healthcare.

History made: Young child treated with new heart device for very first time

A care team in Illinois has performed the first heart procedure of its kind on a two-year-old patient diagnosed with Brugada syndrome.

ACC offers practical approaches for arrhythmia monitoring after stroke

The American College of Cardiology published an expert consensus on practical approaches for arrhythmia monitoring after stroke to improve post-stroke care by identifying and managing atrial fibrillation.

Top videos on the Cardiovascular Business website about new cardiovascular trends and technologies in 2024.

Top cardiology video interviews in 2024

A list of the most popular video interviews on Cardiovascular Business in 2024 based on reader analytics.

FDA announces recall of cryoablation catheters after multiple injuries, including 4 deaths

Boston Scientific is recalling the catheters associated with its POLARx Cryoablation System due to a heightened risk of esophageal injury. The FDA has ruled that this a Class I recall.

Left: Petr Neužil, MD, PhD, head of the department of cardiology at Na Homolce Hospital in Prague, Czech Republic / Right: Vivek Y. Reddy, MD, director of cardiac arrhythmia services at Mount Sinai Hospital in New York City

Cardiologists perform world’s first leadless LBBAP procedures with Abbott pacemaker

The first-in-human procedures were performed in Prague with the investigational Aveir CSP leadless pacemaker system.

Joseph C. Wright resigns from Merit Medical

President of medical device company resigns over conduct allegations after 7 months in role

Joseph C. Wright, a longtime Merit Medical employee, resigned after unspecified allegations regarding his conduct were brought to light. He was named the company's new president back in May.

Boston Scientific recalls more than 200,000 pacemakers after 2 deaths and 697 confirmed malfunctions.

FDA and Boston Scientific issue urgent alert about pacemaker failures following 2 deaths

The U.S. Food and Drug Administration issued the recall notice for more than 200,000 pacemakers because a battery issue could lock the device in safe mode.

A TAVR procedure being performed at Northwestern Medicine in Chicago. These structural heart procedures require a team approach.

Treating AFib patients with TAVR still linked to elevated risks

While the technology and techniques associated with TAVR have advanced over the years, treating patients who present with baseline atrial fibrillation is still associated with certain risks.

Electrophysiology

Abbott PFA system gains FDA approval

New PFA registry will use AI, EHR integration to gather real-world data

Success in treating congenital heart disease prompted need for new adult guidelines

FDA approves new nasal spray for patients with abnormal heart rhythms

FDA clears next-generation cardiac mapping software